TMEM52B and kidney cancer: We also found that kidney cancer patients with tumors that highly expressed TMEM52B (Z > 1.5) had a significantly better overall survival rate than the remaining patients (Z ≤ 1.5) (Supplementary Fig. S6D) from the analysis of TCGA-generated kidney cancer data (TCGA, Firehose Legacy).